Design Therapeautics logo

Design Therapeautics share price today

(DSGN)

Design Therapeautics share price is $6.17 & ₹528.46 as on 1 Jan 2025, 2.30 'hrs' IST

$6.17

Market is closed - opens 8 PM, 02 Jan 2025

View live Design Therapeautics share price in Dollar and Rupees. Guide to invest in Design Therapeautics from India. Also see the sentimental analysis on Indian investors investing in Design Therapeautics. Get details on the Indian mutual funds that are investing in Design Therapeautics. Get Analyst recommendations and forecasts along with all the Design Therapeautics's financials.

Design Therapeautics share price movements

  • Today's Low: $6.11
    Today's High: $6.29

    Day's Volatility :2.94%

  • 52 Weeks Low: $2.25
    52 Weeks High: $7.77

    52 Weeks Volatility :71.11%

Design Therapeautics Returns

PeriodDesign Therapeautics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
30.72%
-10.0%
0.0%
6 Months
80.41%
-4.7%
0.0%
1 Year
146.8%
-0.9%
0.0%
3 Years
-70.46%
-2.4%
-21.2%

Design Therapeautics Key Statistics

in dollars & INR

Previous Close
$6.17
Open
$6.12
Today's High
$6.29
Today's Low
$6.105
Market Capitalization
$349.4M
Today's Volume
$61.2K
52 Week High
$7.77
52 Week Low
$2.245
Revenue TTM
$33.0K
EBITDA
$-60.2M
Earnings Per Share (EPS)
$-0.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-17.78%

How to invest in Design Therapeautics from India?

It is very easy for Indian residents to invest directly in Design Therapeautics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Design Therapeautics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Design Therapeautics or DSGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Design Therapeautics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Design Therapeautics shares which would translate to 0.139 fractional shares of Design Therapeautics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Design Therapeautics, in just a few clicks!

Returns in Design Therapeautics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Design Therapeautics investment value today

Current value as on today

₹2,49,667

Returns

₹1,49,667

(+149.67%)

Returns from Design Therapeautics Stock

₹1,46,800 (+146.8%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Design Therapeautics

-33%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Design Therapeautics on INDmoney from India has reduced in the last 30 days as on Jan 2, 2025. -33% less investors are searching Design Therapeautics in the last 30 days versus the previous period.

Global Institutional Holdings in Design Therapeautics

  • SR ONE CAPITAL MANAGEMENT, LP

    11.53%

  • Logos Global Management LP

    7.45%

  • BlackRock Inc

    4.07%

  • Baker Bros Advisors LP

    3.08%

  • Point72 Asset Management, L.P.

    2.83%

  • TANG CAPITAL MANAGEMENT LLC

    2.62%

Analyst Recommendation on Design Therapeautics

Hold

    0%Buy

    62%Hold

    37%Sell

Based on 8 Wall street analysts offering stock ratings for Design Therapeautics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
5
6
6
Sell
3
3
3

Analyst Forecast on Design Therapeautics

What analysts predicted

Upside of 13.45%

Current:

$6.17

Target:

$7.00

Insights on Design Therapeautics

  • Price Movement

    In the last 6 months, DSGN stock has moved up by 92.8%
  • DSGN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 110.0%

Design Therapeautics Technicals Summary

Sell

Neutral

Buy

Design Therapeautics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Design Therapeautics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Design Therapeautics, Inc.
3.01%
80.41%
146.8%
-70.46%
-85.13%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Design Therapeautics, Inc.
NA
NA
NA
-0.9
-0.18
-0.14
NA
4.46
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Design Therapeautics, Inc.
Hold
$349.4M
-85.13%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Design Therapeautics

Organization
Design Therapeautics
Employees
54
CEO
Mr. Pratik Shah Ph.D.
Industry
Healthcare

Management People of Design Therapeautics

NameTitle
Mr. Pratik Shah Ph.D.
Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
Dr. Sean Jeffries Ph.D.
Chief Operating Officer
Dr. Aseem Z. Ansari Ph.D.
Co-Founder & Scientific Advisor
Ms. Julie D. Burgess CPA
Chief Accounting Officer
Mr. Mustapha Parekh
General Counsel
Dr. Jae B. Kim FACC, M.D.
Consulting Chief Medical Officer
Ms. Dawn Giangiulio
Controller

Important FAQs about investing in Design Therapeautics from India :

What is Design Therapeautics share price today?

Design Therapeautics share price today stands at $6.17, Open: $6.12 ; Previous Close: $6.17 ; High: $6.29 ; Low: $6.11 ; 52 Week High: $7.77 ; 52 Week Low: $2.25. The stock opens at $6.12, after a previous close of $6.17. The stock reached a daily high of $6.29 and a low of $6.11, with a 52-week high of $7.77 and a 52-week low of $2.25.

Can Indians buy Design Therapeautics shares?

Yes, Indians can invest in the Design Therapeautics (DSGN) from India.

With INDmoney, you can buy Design Therapeautics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Design Therapeautics at zero transaction cost.

How can I buy Design Therapeautics shares from India?

It is very easy to buy Design Therapeautics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Design Therapeautics be purchased?

Yes, you can buy fractional shares of Design Therapeautics with INDmoney app.

What are the documents required to start investing in Design Therapeautics stocks?

To start investing in Design Therapeautics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Design Therapeautics

Today’s highest price of Design Therapeautics (DSGN) is $6.29.

Today’s lowest price of Design Therapeautics (DSGN) is $6.11.

What is today's market capitalisation of Design Therapeautics

Today's market capitalisation of Design Therapeautics DSGN is 349.4M

What is the 52 Week High and Low Range of Design Therapeautics

  • 52 Week High

    $7.77

  • 52 Week Low

    $2.25

What are the historical returns of Design Therapeautics?

  • 1 Month Returns

    3.01%

  • 3 Months Returns

    80.41%

  • 1 Year Returns

    146.8%

  • 5 Years Returns

    -85.13%

Who is the Chief Executive Officer (CEO) of Design Therapeautics

Mr. Pratik Shah Ph.D. is the current Chief Executive Officer (CEO) of Design Therapeautics.